24 January 20224 minute read

Leading IP strategists and renowned patent lawyers Raymond Miller, Nicole Endejann and Joseph Helmsen join DLA Piper’s award-winning Intellectual Property and Technology practice and Life Sciences sector

DLA Piper announced today that Raymond Miller, Nicole Endejann and Joseph Helmsen have joined the firm’s industry-renowned Intellectual Property and Technology (IPT) practice and Life Sciences sector as partners. The team has worked together for nearly 20 years and has been recognized in the industry as among the 300 World Leading IP Strategists and among the World’s 1000 best patent practitioners by IAM Media, the definitive resource that identifies world-class, private practice patent expertise.

The group focuses on IP strategies that address complex intellectual property issues that arise in transactions, including mergers and acquisitions. Additionally, the group negotiates licenses, transfer agreements and assignments. Miller, Endejann and Helmsen counsel clients on strategic intellectual property issues in the pharmaceutical, biotechnology, chemical, medical device, IT, digital health and food science areas. They also prepare and prosecute patent applications related to new chemical entities, pharmaceutical formulations and biologics, as well as implantable medical devices, digital therapeutics and software, chemical processes and catalysts, and they are well versed in the interplay of patent and regulatory exclusivity for pharmaceuticals and biologics.

“Ray, Nicole and Joe are well-known thought leaders in life sciences, and their addition to our team will substantially expand our ability to advise on a wide range of sophisticated IP issues,” said Larissa Bifano, US chair of DLA Piper’s Patent Prosecution practice.

“This talented group brings a strong scientific and legal background, including deep knowledge of chemistry, pharmaceuticals and digital health, that will bolster our capacity for complex transactional and litigation work in the life sciences sector,” said Andrew Gilbert, global co-chair of the firm’s Life Sciences sector and US vice chair of the Corporate practice. “Ray, Nicole and Joe will provide crucial IP-related support to venture capital, private equity and capital markets deals, in addition to handling patent prosecution work and IP-related counseling.”

Miller, Endejann and Helmsen all join from Troutman Pepper Hamilton Sanders LLP.